Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 2091

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 2
Chunk 2091
---
 not for the purpose of expressing an opinion on the effectiveness of the Company’s
internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures
included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation
of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

/s/ Wolf & Company, P.C.

We have served as the Company's auditor since 2024.

Boston, MA

April 15, 2025

F-2

CERO THERAPEUTICS HOLDINGS, INC.

CONSOLIDATED
BALANCE SHEETS

    December 31,  
    December 31, 

    2024
 (Successor)  
    2023
 (Predecessor) 
  
    ASSETS 

    Current assets: 

    Cash, restricted cash, and cash equivalents 
    $3,327,060  
    $1,601,255 
  
    Prepaid expenses and other current assets 
     274,749  
     368,780 
  
    Deferred offering costs 
     112,232  
     - 
  
    Total current assets 
     3,714,041  
     1,970,035 

    Deferred offering costs, net of current portion 
     500,000  
     - 
  
    Operating lease right-of-use assets 
     1,464,367  
     2,189,565 
  
    Property and equipment, net 
     528,521  
     966,702 
  
    Total assets 
    $6,206,929 
    $5,126,302 

    LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT 

    Current liabilities: 

    Accounts payable 
    $4,507,318  
    $1,671,745 
  
    Accrued liabilities 
     1,913,175  
     144,633 
  
    Common stock subscription deposit 
     -  
     1,875 
  
    Operating lease liability